Mirum Pharmaceuticals, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 83.94%74.76%75.77%
EBT Margin 30,857.01%-440.05%-184.36%-87.15%-25.80%
EBIT Margin 31,133.13%-906.12%-170.28%-58.57%-26.00%
EBITDA Margin 31,133.13%-906.12%-170.28%-58.57%-26.00%
Operating Margin 31,133.13%-906.12%-170.28%-58.57%-26.00%
Net Margin 30,858.81%-440.24%-176.05%-87.68%-26.10%
FCF Margin 26,656.72%-693.81%-156.26%-38.12%2.77%
Efficiency
Inventory Average 3.54M13.94M22.36M
Assets Average 267.76M323.78M499.76M658.69M
Equity Average 146.15M131.12M195.35M237.16M
Invested Capital 173.36M122.21M143.13M248.67M225.64M
Asset Utilization Ratio 0.070.240.370.51
Leverage & Solvency
Interest Coverage Ratio -311.33-9.86-8.21-7.23-6.12
Debt to Equity 0.010.020.01
Debt Ratio 0.010.010.00
Equity Ratio 0.710.410.400.380.34
Times Interest Earned -311.33-9.86-8.21-7.23-6.12
Valuation
Enterprise Value 563.71M217.20M232.14M467.25M1,089.73M1,704.67M
Market Capitalization 563.71M449.02M488.68M718.97M1,376.05M1,984.99M
Return Ratios
Return on Sales 308.59%-4.40%-1.76%-0.88%-0.26%
Return on Capital Employed -0.77%-0.51%-0.26%-0.16%
Return on Invested Capital -0.94%
Return on Assets -0.31%-0.42%-0.33%-0.13%
Return on Equity -0.58%-1.03%-0.84%-0.37%